Blood Plasma Derivatives Market Size, Report, Demand Analysis 2023-2028

May 9, 2023 vikaschauhan

IMARC Group, a leading market research company, has recently releases report titled “Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global blood plasma derivatives market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How Big is the Blood Plasma Derivatives Market?

Report Attributes	Details
Market Size in 2022	US$ 43.2 Billion
Market Forecast in 2028	US$ 61.9 Billion
Growth rate (2023 to 2028)	CAGR of 6.1%
Base Year of the Analysis	2022
Forecast Period	2023-2028

What is Blood Plasma Derivatives?

Blood plasma derivatives refer to a concentrated form of specific proteins produced from plasma that is obtained through the fractionation process. They can be categorized into various types, such as Factor VIII, albumin, immunoglobulin, factor IX, fresh frozen, etc. Blood plasma derivatives are rich in minerals, proteins, salts, hormones, vitamins, and protease inhibitors, owing to which they are extensively utilized to kill viruses that cause hemophilia A, hepatitis B, immunodeficiency, bleeding disorders, hepatitis C, hemophilia B, human immunodeficiency virus (HIV), etc. Blood plasma derivatives also help in controlling the body temperature, improving nutrition, maintaining osmotic pressure, regulating acid-base balance, and enhancing respiration and excretion processes. Consequently, they find widespread applications in hospitals, clinics, and other healthcare facilities across countries.

Request for a free sample copy of this report: https://www.imarcgroup.com/blood-plasma-derivatives-market/requestsample

What are the growth prospects and trends in the Blood Plasma Derivatives Industry?

The growing geriatric population, which is relatively more susceptible to developing infectious diseases, and the expanding incidences of thrombocytosis are among the key factors augmenting the blood plasma derivatives market.

Additionally, the development of numerous advanced technologies in the fractionation process, which improves the separation of protein concentrates and several other components of blood plasma for clinical purposes, is further catalyzing the market growth. Besides this, the escalating adoption of convalescent plasma treatments to treat patients suffering from COVID-19 is acting as another significant growth-inducing factor.

Furthermore, the introduction of superior preservation methods and the increasing advancements in encased procedures to develop targeted therapeutic products are expected to stimulate the blood plasma derivatives market in the coming years.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others

Breakup by Application:

Hemophilia
Hypogammaglobulinemia
Immunodeficiency Diseases
Von Willebrand’s Disease
Others

Breakup by End User:

Hospitals
Clinics
Others

Breakup by Region:

North America: (United States, Canada)
Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5371&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/